Goldman Sachs’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $259K | Sell |
|
|||||
|
2025
Q2 | $2.77M | Buy |
|
|||||
|
2025
Q1 | $2.39M | Buy |
|
|||||
|
2024
Q4 | $2.37M | Buy |
|
|||||
|
2024
Q3 | $408K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $334K | Sell |
|
|||||
|
2023
Q1 | $472K | Buy |
|
|||||
|
2022
Q4 | $471K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $453K | Sell |
|
|||||
|
2021
Q3 | $1M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $256K | Sell |
|
|||||
|
2017
Q2 | $297K | Sell |
|
|||||
|
2017
Q1 | $522K | Sell |
|
|||||
|
2016
Q4 | $2.57M | Buy |
|
|||||
|
2016
Q3 | $2.78M | Sell |
|
|||||
|
2016
Q2 | $2.47M | Buy |
|
|||||
|
2016
Q1 | $2.56M | Buy |
|
|||||
|
2015
Q4 | $3.35M | Sell |
|
|||||
|
2015
Q3 | $3.05M | Sell |
|
|||||
|
2015
Q2 | $3.97M | Sell |
|
|||||
|
2015
Q1 | $3.84M | Buy |
|
|||||
|
2014
Q4 | $3.23M | Sell |
|
|||||
|
2014
Q3 | $3.02M | Sell |
|
|||||
|
2014
Q2 | $4M | Buy |
|
|||||
|
2014
Q1 | $862K | Buy |
|
|||||
|
2013
Q4 | $382K | Buy |
|